{"id":1538,"date":"2018-09-10T12:46:43","date_gmt":"2018-09-10T12:46:43","guid":{"rendered":"http:\/\/law-firm.bold-themes.com\/master-import\/?page_id=7"},"modified":"2023-10-25T14:06:37","modified_gmt":"2023-10-25T14:06:37","slug":"home","status":"publish","type":"page","link":"https:\/\/stuarttherapeutics.com\/","title":{"rendered":"Home"},"content":{"rendered":"
<\/a><\/p>\n<\/div> <\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section> NEWS UPDATE: Stuart Therapeutics announces Exclusive Worldwide License Agreement with Glaukos Corporation<\/strong><\/span><\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section> Dry Eye Disease is a challenging disease of the ocular surface that causes eye pain, inflammation, and difficulty dealing with daily tasks.<\/p>\n<\/div><\/div><\/div><\/div> Glaucoma is a slow acting disease, and damage is irreversible. Proper diagnosis and intervention is critical.<\/p>\n<\/div> Imagine you are looking at a clock with hands. With Dry Age-Related Macular Degeneration (Dry AMD), you might see the clock\u2019s numbers, but not the hands.<\/p>\n<\/div> Stuart Therapeutics (Stuart) is a clinical stage pharmaceutical company focused on the development of a unique synthetic protein designed to target a previously undruggable target in the human body: helical collagen. The company\u2019s platform technology, called PolyColTM <\/sup>(PolyCol<\/em><\/strong>), is a series of synthesized amino acid sequences designed to specifically bind to and repair disease-damaged helical collagen in the extracellular matrix and in membranes.\u00a0 These helical collagen structures play an important role in healthy tissues, including the regulation of inflammation, cell growth and proliferation, among many other processes.<\/p>\n \u00a0<\/span><\/p>\n<\/div> Stuart was founded in 2018 to champion a new approach to the treatment of chronic diseases. \u00a0Each of our founders has been affected directly or indirectly by chronic eye disease, and we have a passion for the pursuit of new and effective solutions for these indications.<\/p>\n Stuart\u2019s areas of interest are Dry Eye Disease, Glaucoma, Dry Age-Related Macular Degeneration and Myopia.\u201d<\/p>\n<\/div>Our Expertise<\/span><\/span><\/h3><\/header>
OUR FOCUS<\/span><\/h6>\n<\/div>
Dry Eye Disease<\/span><\/a><\/h4>\n<\/div>
OUR FOCUS<\/span><\/h6>\n<\/div>
Glaucoma<\/span><\/a><\/h4>\n<\/div>
OUR FOCUS<\/span><\/h6>\n<\/div>
Dry AMD<\/span><\/a><\/h4>\n<\/div>
WHO WE ARE<\/span><\/h6>\n<\/div>
Stuart Therapeutics<\/span><\/h4>\n<\/div>
News and Resources<\/span><\/span><\/h3><\/header>